Form 8-K - Current report:
SEC Accession No. 0001564590-21-059679
Filing Date
2021-12-08
Accepted
2021-12-08 06:02:57
Documents
13
Period of Report
2021-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 DEPARTURE OF DIRECTOR OR CERTAIN OFFICER grph-8k_20211206.htm   iXBRL 8-K 34162
  Complete submission text file 0001564590-21-059679.txt   197541

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grph-20211206.xsd EX-101.SCH 5929
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grph-20211206_def.xml EX-101.DEF 13779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20211206_lab.xml EX-101.LAB 23752
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20211206_pre.xml EX-101.PRE 14568
6 EXTRACTED XBRL INSTANCE DOCUMENT grph-8k_20211206_htm.xml XML 5271
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 211477564
SIC: 2836 Biological Products, (No Diagnostic Substances)